Objective: To clarify the effects of bedtime administration of the centrally acting α2-agonists, guanabenz and clonidine, on morning hypertension. Methods: Patients with morning hypertension were assigned to receive once-daily evening administration of guanabenz (2 mg/day, n = 81; 4 mg/day, n = 2) or clonidine (75 μg/day, n = 40; 150 μg/day, n = 10) for 4 weeks, and the blood pressure (BP)-lowering effects of these drugs in the morning and evening were evaluated by assessing self-monitored BP in the home environment. The subjects were then subdivided into different groups according to their evening BP, and the effects of guanabenz and clonidine on evening BP were evaluated further for each group. In addition, as a substitute for the trough/peak ratio, the evening/morning (E/M) ratio was calculated to assess the duration of action of the two α2-agonists. Results: Evening dosing with guanabenz or clonidine lowered morning BP significantly. Both drugs decreased evening BP in the subgroup of subjects with a high evening BP, but not in those with a normal evening BP. The individual E/M ratios for guanabenz, but not for clonidine, were significantly greater in those with a high evening BP than in those with a normal evening BP. In the early treatment period, treatment with guanabenz resulted in a higher diastolic E/M ratio in those subjects with a high evening diastolic BP than did treatment with clonidine. Conclusion: The results suggest that evening administration of the central α2-agonists guanabenz and clonidine effectively suppresses the morning BP elevation in treated hypertensive patients.
- Home blood pressure
ASJC Scopus subject areas
- Internal Medicine
- Cardiology and Cardiovascular Medicine